Medical management of primary hypertension. 2.
D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D004232:Diuretics / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D010953:Plasma Volume / Q000187:drug effects; D011926:Rauwolfia / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects
D004232:Diuretics; D006830:Hydralazine; D008750:Methyldopa